Sensei Biotherapeutics
(NASDAQ:SNSE)
$0.659
0.05[8.57%]
At close: Jun 21
$0.659
-0[-0.24%]
After Hours: 4:17PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$12.00
Lowest Price Target1
$4.00
Consensus Price Target1
$5.71

Sensei Biotherapeutics (NASDAQ:SNSE) Stock, Analyst Ratings, Price Targets, Predictions

Sensei Biotherapeutics Inc has a consensus price target of $5.71, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from Citigroup, HC Wainwright & Co., and Stephens & Co. on June 3, 2024, May 24, 2024, and May 24, 2024. With an average price target of $4.33 between Citigroup, HC Wainwright & Co., and Stephens & Co., there's an implied 559.16% upside for Sensei Biotherapeutics Inc from these 3 analyst ratings.

Analyst Trends and Forecast
2
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Citigroup
HC Wainwright & Co.
Stephens & Co.
Oppenheimer
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Sensei Biotherapeutics

Buy NowGet Alert
06/03/2024Buy Now508.46%Citigroup
Samantha Semenkow
→ $4ReinstatesBuy → BuyGet Alert
05/24/2024Buy Now508.46%HC Wainwright & Co.
Edward White
→ $4ReiteratesBuy → BuyGet Alert
05/24/2024Buy Now660.57%Stephens & Co.
Sudan Loganathan
$5 → $5ReiteratesOverweight → OverweightGet Alert
05/14/2024Buy Now660.57%Stephens & Co.
Sudan Loganathan
→ $5Initiates → OverweightGet Alert
12/04/2023Buy Now508.46%HC Wainwright & Co.
Edward White
→ $4Initiates → BuyGet Alert
12/13/2022Buy Now812.69%Citigroup
Samantha Semenkow
→ $6Initiates → BuyGet Alert
10/03/2022Buy Now660.57%Oppenheimer
Francois Brisebois
→ $5UpgradePerform → OutperformGet Alert
03/10/2022Buy Now1421.14%Piper Sandler
Joseph Catanzaro
$12 → $10MaintainsOverweightGet Alert
07/01/2021Buy Now1725.37%Berenberg
Zhiqiang Shu
DowngradeBuy → HoldGet Alert
06/29/2021Buy NowOppenheimer
Kevin DeGeeter
DowngradeOutperform → PerformGet Alert

FAQ

Q

What is the target price for Sensei Biotherapeutics (SNSE) stock?

A

The latest price target for Sensei Biotherapeutics (NASDAQ:SNSE) was reported by Citigroup on June 3, 2024. The analyst firm set a price target for $4.00 expecting SNSE to rise to within 12 months (a possible 508.46% upside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Sensei Biotherapeutics (SNSE)?

A

The latest analyst rating for Sensei Biotherapeutics (NASDAQ:SNSE) was provided by Citigroup, and Sensei Biotherapeutics their buy rating.

Q

When was the last upgrade for Sensei Biotherapeutics (SNSE)?

A

The last upgrade for Sensei Biotherapeutics Inc happened on October 3, 2022 when Oppenheimer raised their price target to $5. Oppenheimer previously had a perform for Sensei Biotherapeutics Inc.

Q

When was the last downgrade for Sensei Biotherapeutics (SNSE)?

A

The last downgrade for Sensei Biotherapeutics Inc happened on July 1, 2021 when Berenberg changed their price target from N/A to $12 for Sensei Biotherapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Sensei Biotherapeutics (SNSE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensei Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensei Biotherapeutics was filed on June 3, 2024 so you should expect the next rating to be made available sometime around June 3, 2025.

Q

Is the Analyst Rating Sensei Biotherapeutics (SNSE) correct?

A

While ratings are subjective and will change, the latest Sensei Biotherapeutics (SNSE) rating was a with a price target of $0.00 to $4.00. The current price Sensei Biotherapeutics (SNSE) is trading at is $0.66, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch